Filing Details

Accession Number:
0001318568-20-000273
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-07 21:45:46
Reporting Period:
2020-12-07
Accepted Time:
2020-12-07 21:45:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1318568 Everi Holdings Inc. EVRI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254422 L Randy Taylor 7250 S Tenaya Way
Suite 100
Las Vegas NV 89113
President & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-07 15,000 $4.57 129,320 No 4 M Direct
Common Stock Disposition 2020-12-07 15,000 $12.52 114,320 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-12-07 15,000 $0.00 15,000 $4.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-12-07 No 4 M Direct
Footnotes
  1. The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on November 6, 2020. The plan provides for a maximum number of common shares of 15,000, which were part of an award originally granted on December 7, 2011, which were to be sold based on options that would have expired on December 7, 2021.
  2. The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a prices ranging from $12.28 to $12.80. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Represents an option to purchase 30,000 shares of the Company's stock, which vested periodically over a period of four years following the date of grant.